Literature DB >> 2526851

Prostaglandins from human T suppressor/cytotoxic cells modulate natural killer antibacterial activity.

P Garcia-Peñarrubia1, A D Bankhurst, F T Koster.   

Abstract

We have recently described potent antibacterial activity of purified human NK cells. Here we show that this function is regulated by T cytotoxic/suppressor CD8+ cells. Thus, coculture of NK and CD8+ cells for 3 h or longer times abrogated the expression of the NK antibacterial activity, and of two activation markers IL-2R and transferrin receptor (Tf-R). The suppressive activity was mediated by PGE2 as demonstrated by direct PGE2 determination in CD8+ cell free supernatants, and by inhibition of CD8+ cell suppression with indomethacin or piroxicam in vitro. We also found that resting T cytotoxic/suppressor cells purified by negative selection produce higher amounts of PGE2 than adherent cells like monocytes and macrophages, and that these concentration levels are in the range of concentrations known to suppress a significant number of in vitro immunologic functions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526851      PMCID: PMC2189404          DOI: 10.1084/jem.170.2.601

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Suppression of natural killer cell cytotoxicity by splenocytes from Corynebacterium parvum-injected, bone marrow-tolerant, and infant mice.

Authors:  C A Savary; E Lotzová
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity.

Authors:  N P Lang; J R Ortaldo; G D Bonnard; R B Herberman
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

3.  Suppressor cells of the human NK activity: characterization of the cells and mechanism of action.

Authors:  J Tarkkanen; E Saksela; E von Willebrand; E Lehtonen
Journal:  Cell Immunol       Date:  1983-07-15       Impact factor: 4.868

4.  Suppression of natural killer activity in human blood and bone marrow cultures by bone marrow-adherent OKM1-positive cells.

Authors:  C J Punjabi; M A Moore; P Ralph
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

Review 5.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

6.  In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells.

Authors:  M S Kennedy; J D Stobo; M E Goldyne
Journal:  Prostaglandins       Date:  1980-07

7.  Suppressor cells of natural killer activity in normal and tumor-bearing individuals.

Authors:  J Tarkkanen; E Saksela; M Paavolainen
Journal:  Clin Immunol Immunopathol       Date:  1983-07

8.  Inhibition of natural killer cell activity by a soluble substance released by rat peritoneal cells.

Authors:  J Zighelboim; A Lichtenstein; A Bick; R Mickel
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

9.  Modulation of human natural killer cell activity by pharmacological mediators.

Authors:  T J Hall; S H Chen; J Brostoff; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  10 in total

1.  Francisella tularensis LVS induction of prostaglandin biosynthesis by infected macrophages requires specific host phospholipases and lipid phosphatases.

Authors:  Aaron R Navratil; Ashley M Brummett; Joshua D Bryan; Matthew D Woolard
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

Review 2.  Regulation of immune responses by prostaglandin E2.

Authors:  Pawel Kalinski
Journal:  J Immunol       Date:  2012-01-01       Impact factor: 5.422

3.  Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.

Authors:  A Molloy; G Gaudernack; W R Levis; Z A Cohn; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  In vitro prostaglandin E2 production by glioblastoma cells and its effect on interleukin-2 activation of oncolytic lymphocytes.

Authors:  Y Sawamura; A C Diserens; N de Tribolet
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

5.  Induction of IgM and IgM-rheumatoid factor synthesis in vitro by indomethacin.

Authors:  J Hassan; A Whelan; B Bresnihan; C Feighery
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 6.  The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1996-09       Impact factor: 6.968

7.  Mechanisms of inhibition of Cryptococcus neoformans by human lymphocytes.

Authors:  S M Levitz; E A North; M P Dupont; T S Harrison
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 8.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

Review 9.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

10.  Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.

Authors:  Y Nishigaki; H Ohnishi; H Moriwaki; Y Muto
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.